Results 201 to 210 of about 28,421 (276)

Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures

EBioMedicine
Theresa E. Schäfer, L. Knol, Ferdinand V. Haas, Anna Hartley, Sophie C.S. Pernickel, Attila Jády, Maximiliane S. C. Finkbeiner, Johannes Achberger, Stella Arelaki, Živa Modic, Katrin Schröer, Wenli Zhang, Barbara Schmidt, P. Schuster, S. Haferkamp, J. Doerner, Florian Gebauer, M. Ackermann, H. Kvasnicka, Amit A. Kulkarni, Selas T F Bots, V. Kemp, L. Hawinkels, A. Poetsch, R. Hoeben, Anja Ehrhardt, Antonio Marchini, G. Ungerechts, Claudia R. Ball, C. E. Engeland   +29 more
semanticscholar   +1 more source

Fusing Oncolytic Virotherapy With Cancer Immunotherapy to Treat Therapy-Resistant Melanoma. [PDF]

J Clin Oncol
Vile RG.
europepmc   +1 more source

Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment [PDF]

, 2019
Iris Koske, Annika Rössler, Lisa Pipperger, Monika Petersson, Isabel Barnstorf, Janine Kimpel, Christoph H. Tripp, Patrizia Stoitzner, Zoltán Bánki, Dorotheé von Laer   +9 more
openalex   +1 more source

Multiparametric Detection of Effects of TILs and Oncolytic Virotherapy on Xenograft Mouse Model of Glioblastoma. [PDF]

Biomedicines
Yusubalieva GM, Chudakova DA, Shirokikh PG, Yuzhakova DV, Kiseleva EB, Sachkova DA, Dudenkova VV, Kirsova DP, Myzina MS, Yanysheva EP, Panov AV, Zakirova NF, Poteryakhina AV, Semikhin AS, Kalinkin AA, Baklaushev VP.   +15 more
europepmc   +1 more source

IMMU-19. COMBINATION IMMUNOTHERAPY SEQUENCE MATTERS: VACCINE PRIOR TO ONCOLYTIC HSV VIROTHERAPY ENHANCES TUMOR-SPECIFIC T CELL RESPONSES AND EFFICACY [PDF]

Kyung‐Don Kang, Stacie K. Totsch, Andrew S. Ishizuka, Sam E. Gary, Abbey Rocco, Aaron E. Fan, Li Zhou, Pablo A. Valdés, SeungHo Lee, Jason Li, Luca Peruzzotti‐Jametti, Sarah E. Blitz, Christopher M. Garliss, James M. Johnston, James M. Markert, Geoffrey M. Lynn, Joshua D. Bernstock, Gregory K. Friedman   +17 more
openalex   +1 more source

24. Human Bone Marrow-Derived Mesenchymal Stromal Cells Permit Delivery, and Enhance Efficacy of Systemically Administered Oncolytic Measles Virotherapy to Disseminated Human Pre-B ALL Murine Xenograft Models in the Presence of Humoral Immunity [PDF]

, 2013

openalex   +1 more source

Oncolytic Virotherapy for Glioma: A Bibliometric Roadmap for Multidisciplinary Clinical and Research Strategies. [PDF]

J Multidiscip Healthc
Liu S, Liang R.
europepmc   +1 more source

Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial

Nature Medicine, 2023
H. Soliman, D. Hogue, H. Han, Blaise Mooney, R. Costa, Marie Catherine Lee, B. Niell, Angela Williams, A. Chau, Shannon Falcon, A. Soyano, Avan J Armaghani, N. Khakpour, R. Weinfurtner, S. Hoover, J. Kiluk, C. Laronga, M. Rosa, H. Khong, B. Czerniecki   +19 more
semanticscholar   +1 more source

Immune Checkpoint Inhibitors Combined with Oncolytic Virotherapy: Synergy, Heterogeneity, and Safety in Cancer Treatment. [PDF]

Oncol Res
Feng Y, Yang H, Liang G, Chen J, Li T, Wang Y, Chang J, Li Y, Yang M, Zhou X, Wang Z, Ge C.   +11 more
europepmc   +1 more source

Transforming the prostatic tumor microenvironment with oncolytic virotherapy [PDF]

, 2018
Matthew J. Atherton, Kyle B. Stephenson, Fanny Tzelepis, David Bakhshinyan, Jake K. Nikota, Hwan Hee Son, Anna Jirovec, Charles Lefebvre, Anna Dvorkin‐Gheva, Ali A. Ashkar, Yonghong Wan, David F. Stojdl, Eric C. Bélanger, Rodney H. Breau, John C. Bell, Fred Saad, Sheila K. Singh, Jean-Simone Diallo, Brian D. Lichty   +18 more
openalex   +1 more source